Boeckxstaens G E, Hollmann M, Heisterkamp S H, Robberecht P, de Jonge W J, van Den Wijngaard R M, Tytgat G N, Blommaart P J
Division of Gastroenterology & Hepatology, Academic Medical Center, Amsterdam, The Netherlands.
Br J Pharmacol. 2000 Oct;131(4):705-10. doi: 10.1038/sj.bjp.0703625.
We previously reported activation of an inhibitory adrenergic and a non-adrenergic non-cholinergic (NANC) pathway during abdominal surgery relaxing the rat gastric fundus. In the present study, we investigated the possible role of nitric oxide (NO) and vasoactive intestinal polypeptide (VIP) in the NANC part of the surgery-induced fundic relaxation. The effect of the NO biosynthesis inhibitor N(G)-nitro-L-arginine (L-NOARG), the non-selective VIP receptor antagonist [D-p-Cl-Phe(6),Leu(17)]-VIP and the selective VIP(1) receptor antagonist [Acetyl-His(1),D-Phe(2),Lys(15),Arg(16), Leu(17)]-VIP was investigated on the non-adrenergic fundic relaxation induced by manipulation of the small intestine followed by resection of the caecum. Guanethidine partly reduced the manipulation-induced fundic relaxation. Addition of L-NOARG reduced this non-adrenergic component, whereas the non-selective VIP receptor antagonist had no significant effect. Combination of L-NOARG and the non-selective VIP antagonist however further reduced the relaxation to manipulation. The selective VIP(1) receptor antagonist reduced the mean and maximal relaxation induced by abdominal surgery in the presence of guanethidine. When combined with L-NOARG, the relaxation of the gastric fundus was almost completely abolished. The VIP(1) receptor antagonist alone had no significant effect on the mean and maximal relaxation, but enhanced recovery of fundic tone. In conclusion, as VIP(1) receptors are not present in the rat gastric fundus, these results suggest that the NANC inhibitory pathway activated during abdominal surgery involves VIP(1) receptors, most likely in the afferent limb. The inhibitory neurotransmitters released at the level of the gastric fundus smooth muscle are NO and a substance different from VIP.
我们之前报道过,腹部手术期间激活了一条抑制性肾上腺素能和一条非肾上腺素能非胆碱能(NANC)通路,使大鼠胃底松弛。在本研究中,我们调查了一氧化氮(NO)和血管活性肠肽(VIP)在手术诱导的胃底松弛的NANC部分中可能发挥的作用。研究了NO生物合成抑制剂N(G)-硝基-L-精氨酸(L-NOARG)、非选择性VIP受体拮抗剂[D-p-Cl-Phe(6),Leu(17)]-VIP和选择性VIP(1)受体拮抗剂[乙酰-His(1),D-Phe(2),Lys(15),Arg(16),Leu(17)]-VIP对小肠操作后切除盲肠诱导的非肾上腺素能胃底松弛的影响。胍乙啶部分降低了操作诱导的胃底松弛。添加L-NOARG降低了这种非肾上腺素能成分,而非选择性VIP受体拮抗剂没有显著影响。然而,L-NOARG和非选择性VIP拮抗剂联合使用进一步降低了对操作的松弛反应。在存在胍乙啶的情况下,选择性VIP(1)受体拮抗剂降低了腹部手术诱导的平均和最大松弛。当与L-NOARG联合使用时,胃底的松弛几乎完全被消除。单独使用VIP(1)受体拮抗剂对平均和最大松弛没有显著影响,但增强了胃底张力的恢复。总之,由于大鼠胃底不存在VIP(1)受体,这些结果表明,腹部手术期间激活的NANC抑制性通路涉及VIP(1)受体,最有可能在传入支。在胃底平滑肌水平释放的抑制性神经递质是NO和一种不同于VIP的物质。